1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Hematology Tests Overview

3 Products under Development
3.1 Hematology Tests - Pipeline Products by Stage of Development
3.2 Hematology Tests - Pipeline Products by Segment
3.3 Hematology Tests - Pipeline Products by Territory
3.4 Hematology Tests - Pipeline Products by Regulatory Path
3.5 Hematology Tests - Pipeline Products by Estimated Approval Date

4 Hematology Tests - Pipeline Products under Development by Companies
4.1 Hematology Tests Companies - Pipeline Products by Stage of Development
4.2 Hematology Tests - Pipeline Products by Stage of Development

5 Hematology Tests Companies and Product Overview
5.1 Aptitude Medical Systems Inc Company Overview
5.1.1 Aptitude Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 ARUP Laboratories Company Overview
5.2.1 ARUP Laboratories Pipeline Products & Ongoing Clinical Trials Overview
5.3 BioMedomics Inc Company Overview
5.3.1 BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Biosurfit, SA Company Overview
5.4.1 Biosurfit, SA Pipeline Products & Ongoing Clinical Trials Overview
5.5 DxDiscovery Inc Company Overview
5.5.1 DxDiscovery Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Dynasil Corporation of America Company Overview
5.6.1 Dynasil Corporation of America Pipeline Products & Ongoing Clinical Trials Overview
5.7 ET Healthcare Inc Company Overview
5.7.1 ET Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 genedrive plc Company Overview
5.8.1 genedrive plc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Group K Diagnostics Company Overview
5.9.1 Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
5.10 hemCheck Sweden AB Company Overview
5.10.1 hemCheck Sweden AB Pipeline Products & Ongoing Clinical Trials Overview
5.11 Ohio State University Company Overview
5.11.1 Ohio State University Pipeline Products & Ongoing Clinical Trials Overview
5.12 Optolane Technologies Inc Company Overview
5.12.1 Optolane Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.13 PortaScience Inc Company Overview
5.13.1 PortaScience Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 Retham Technologies LLC Company Overview
5.14.1 Retham Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.15 Sanguina LLC Company Overview
5.15.1 Sanguina LLC Pipeline Products & Ongoing Clinical Trials Overview
5.16 Siemens Healthcare Diagnostics Inc Company Overview
5.16.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.17 Silver Lake Research Corporation Company Overview
5.17.1 Silver Lake Research Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.18 T2 Biosystems Inc Company Overview
5.18.1 T2 Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.19 University of Melbourne Company Overview
5.19.1 University of Melbourne Pipeline Products & Ongoing Clinical Trials Overview
5.20 VitaMe Technologies Inc Company Overview
5.20.1 VitaMe Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

6 Hematology Tests- Recent Developments
6.1 Jun 17, 2020: Sysmex launches flow cytometer XF-1600 in North America
6.2 Jun 09, 2020: Siemens and Exyte join forces to deliver integrated solutions for fast-track construction of smart biotech facilities
6.3 May 02, 2020: Halo provides operational update
6.4 Feb 20, 2020: FDA files ARUP Laboratories' AAV5 CDx for hemophilia A gene therapy treatment
6.5 Feb 20, 2020: BioMarin's Biologics license application for valoctocogene roxaparvovec accepted for priority review by FDA with review action date of August 21, 2020
6.6 Feb 19, 2020: Biohit Group financial statement release 2019
6.7 Feb 13, 2020: Bio-Rad reports fourth-quarter and full-year 2019 financial results
6.8 Feb 12, 2020: Halo announces promotion of Katie Field to President of Halo and provides Bophelo Bioscience update
6.9 Feb 12, 2020: Quidel reports fourth quarter and full year 2019 financial results
6.10 Feb 07, 2020: User survey at Capio S:t Göran's hospital show 100% support from participating staff for Hemcheck's product concept
6.11 Feb 04, 2020: T2 Biosystems announces participation at Clinical Conferences in February
6.12 Feb 04, 2020: Bio-Rad brings FCS express flow cytometry analysis software to ZE5 cell analyzer users
6.13 Feb 03, 2020: Siemens Healthineers starts new fiscal year with strong growth - outlook confirmed
6.14 Jan 15, 2020: Accellix announces the appointment of Nir Nimrodi as chairman and chief executive officer
6.15 Jan 11, 2020: Study completed at Capio S:t Goran's hospital showing significantly lower frequency of hemolysed blood samples at the emergency care unit when using Hemcheck's product concept
6.16 Jan 09, 2020: Quidel announces preliminary revenue for fourth quarter 2019
6.17 Jan 06, 2020: Bio-Rad appoints Dara Grantham Wright Executive Vice President and Clinical Diagnostics Group President
6.18 Dec 23, 2019: The International Trade Commission issues final decision affirming 10X Genomics infringement of three of Bio-Rad's Patents
6.19 Dec 13, 2019: Bio-Rad makes progress recovering from recent ransomware attack
6.20 Dec 11, 2019: Medica 2019 World Forum of Medicine
6.21 Dec 10, 2019: Siemens Healthineers gives details on second phase of Strategy 2025 and on the further development of its businesses
6.22 Dec 05, 2019: Akers Biosciences continues strategic review; explores leveraging its 30-years of laboratory operations to enter into the hemp and minor cannabinoid processing industry
6.23 Dec 03, 2019: Consort Medical: Interim results of 2019

7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

List of Tables
Table 1: Hematology Tests - Pipeline Products by Stage of Development
Table 2: Hematology Tests - Pipeline Products by Segment
Table 3: Hematology Tests - Pipeline Products by Territory
Table 4: Hematology Tests - Pipeline Products by Regulatory Path
Table 5: Hematology Tests - Pipeline Products by Estimated Approval Date
Table 6: Hematology Tests Companies - Pipeline Products by Stage of Development
Table 7: Hematology Tests - Pipeline Products by Stage of Development
Table 8: Aptitude Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: POC Test - Trauma Coagulopathy - Product Status
Table 10: POC Test - Trauma Coagulopathy - Product Description
Table 11: ARUP Laboratories Pipeline Products & Ongoing Clinical Trials Overview
Table 12: AAV5 Total Antibody Assay - Product Status
Table 13: AAV5 Total Antibody Assay - Product Description
Table 14: BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Fetomaternal Hemorrhage Test - Product Status
Table 16: Fetomaternal Hemorrhage Test - Product Description
Table 17: Hemo SCAN - Product Status
Table 18: Hemo SCAN - Product Description
Table 19: Hemo SCAN S - Product Status
Table 20: Hemo SCAN S - Product Description
Table 21: Rapid Quantitative Heparin-Induced Thrombocytopenia (H.I.T.) Test - Product Status
Table 22: Rapid Quantitative Heparin-Induced Thrombocytopenia (H.I.T.) Test - Product Description
Table 23: Sickle SCAN - Product Status
Table 24: Sickle SCAN - Product Description
Table 25: Biosurfit, SA Pipeline Products & Ongoing Clinical Trials Overview
Table 26: Spinit Device - Blood Quantitation Anemia Assay - Product Status
Table 27: Spinit Device - Blood Quantitation Anemia Assay - Product Description
Table 28: Spinit Device - Thrombocytopenia Assay - Product Status
Table 29: Spinit Device - Thrombocytopenia Assay - Product Description
Table 30: DxDiscovery Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Diagnostic Assay - Sickle Cell Disease - Product Status
Table 32: Diagnostic Assay - Sickle Cell Disease - Product Description
Table 33: Dynasil Corporation of America Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Diagnostic Test - Hemophilia - Product Status
Table 35: Diagnostic Test - Hemophilia - Product Description
Table 36: ET Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Pylon Assay - D-Dimer - Product Status
Table 38: Pylon Assay - D-Dimer - Product Description
Table 39: genedrive plc Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Genedrive - Factor V Leiden - Product Status
Table 41: Genedrive - Factor V Leiden - Product Description
Table 42: Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 43: KromaHealth Kit - Complete Blood Count - Product Status
Table 44: KromaHealth Kit - Complete Blood Count - Product Description
Table 45: hemCheck Sweden AB Pipeline Products & Ongoing Clinical Trials Overview
Table 46: v-Test - Serum Tubes - Product Status
Table 47: v-Test - Serum Tubes - Product Description
Table 48: Ohio State University Pipeline Products & Ongoing Clinical Trials Overview
Table 49: Diagnostic Assay - Thrombotic Thrombocytopenic Purpura - Product Status
Table 50: Diagnostic Assay - Thrombotic Thrombocytopenic Purpura - Product Description

List of Figures
Figure 1: Hematology Tests - Pipeline Products by Stage of Development
Figure 2: Hematology Tests - Pipeline Products by Segment
Figure 3: Hematology Tests - Pipeline Products by Territory
Figure 4: Hematology Tests - Pipeline Products by Regulatory Path
Figure 5: Hematology Tests - Pipeline Products by Estimated Approval Date

Companies Mentioned
- Aptitude Medical Systems Inc
- ARUP Laboratories
- BioMedomics Inc
- Biosurfit, SA
- DxDiscovery Inc
- Dynasil Corporation of America
- ET Healthcare Inc
- genedrive plc
- Group K Diagnostics
- hemCheck Sweden AB
- Ohio State University
- Optolane Technologies Inc
- PortaScience Inc
- Retham Technologies LLC
- Sanguina LLC
- Siemens Healthcare Diagnostics Inc
- Silver Lake Research Corporation
- T2 Biosystems Inc
- University of Melbourne
- VitaMe Technologies Inc